However, the relationship between C-reactive protein concentrations and conventional clinicopathological criteria is not clear, since some of the above studies have included patients with Dukes A tumours who were unlikely to progress and patients with Dukes D tumours who had already progressed (Wigmore et al, 2001; Chung and Chang, 2003). The gene discussed is CRP; the disease is neoplasm.